Vial

Vial is a next-generation biotechnology company focused on advancing immunology programs into clinical phases with a unique model that combines computational discovery and automated clinical trials. By leveraging technology, Vial dramatically reduces the cost and time of clinical trials, delivering therapeutics with best-in-class, differentiated profiles efficiently. Vial's hyper-scalable model is powered by a computational discovery engine and aims to enhance precision and efficiency in drug development through its automated clinical trial processes. The company is actively hiring to expand its innovative team.